DK0417003T3 - Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation - Google Patents

Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation

Info

Publication number
DK0417003T3
DK0417003T3 DK90402449.4T DK90402449T DK0417003T3 DK 0417003 T3 DK0417003 T3 DK 0417003T3 DK 90402449 T DK90402449 T DK 90402449T DK 0417003 T3 DK0417003 T3 DK 0417003T3
Authority
DK
Denmark
Prior art keywords
antiprogestomimetic
compounds
promote ovulation
ovulation
promote
Prior art date
Application number
DK90402449.4T
Other languages
Danish (da)
English (en)
Inventor
Jean Andre Grandadam
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DK0417003T3 publication Critical patent/DK0417003T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90402449.4T 1989-09-07 1990-09-06 Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation DK0417003T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911699A FR2651435A1 (fr) 1989-09-07 1989-09-07 Nouvelle utilisation de composes anti-progestomimetiques.

Publications (1)

Publication Number Publication Date
DK0417003T3 true DK0417003T3 (da) 1994-07-25

Family

ID=9385212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90402449.4T DK0417003T3 (da) 1989-09-07 1990-09-06 Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation

Country Status (10)

Country Link
US (1) US5173483A (cg-RX-API-DMAC7.html)
EP (1) EP0417003B1 (cg-RX-API-DMAC7.html)
JP (1) JP3032258B2 (cg-RX-API-DMAC7.html)
KR (1) KR0180225B1 (cg-RX-API-DMAC7.html)
AT (1) ATE107859T1 (cg-RX-API-DMAC7.html)
AU (1) AU623805B2 (cg-RX-API-DMAC7.html)
CA (1) CA2024728A1 (cg-RX-API-DMAC7.html)
DE (1) DE69010294T2 (cg-RX-API-DMAC7.html)
DK (1) DK0417003T3 (cg-RX-API-DMAC7.html)
FR (1) FR2651435A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718138B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Nouveaux stéroïdes comportant en position 20 une chaîne aminosubstituée, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les renfermant.
ATE156836T1 (de) * 1994-05-19 1997-08-15 Akzo Nobel Nv 11,21-bisphenyl-19-nor-pregnan derivate
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0900234B1 (en) 1996-05-01 2000-07-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
ATE376839T1 (de) * 2001-12-21 2007-11-15 Pantarhei Bioscience Bv Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren
EP1613640A4 (en) * 2003-02-28 2010-05-19 Us Gov Health & Human Serv PROCESS FOR PREPARING 17 ALPHA-ACETOXY-11 BETA- (4-N, N-DIMETHYLAMINOPHENYL) -19-NORPREGNA-4,9-DIENE-3,20-DION, INTERMEDIATE PRODUCTS AND METHOD OF MANUFACTURING THESE INTERMEDIATE PRODUCTS
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CA3009525A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
CN108699102A (zh) 2015-12-23 2018-10-23 欧瑞克制药公司 糖皮质激素受体抑制剂
PT3523315T (pt) 2016-10-07 2021-04-29 Oric Pharmaceuticals Inc Inibidor de recetor de glucocorticoide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2625505B2 (fr) * 1981-01-09 1991-05-10 Roussel Uclaf Nouveaux derives steroides substitues en 11beta leur procede de preparation et leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3200459A1 (de) * 1982-01-09 1983-07-21 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der azyklie bei schafen oder rindern
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese

Also Published As

Publication number Publication date
EP0417003A3 (en) 1991-12-04
KR910005873A (ko) 1991-04-27
KR0180225B1 (ko) 1999-03-20
EP0417003A2 (fr) 1991-03-13
AU6225990A (en) 1991-03-14
JP3032258B2 (ja) 2000-04-10
DE69010294T2 (de) 1994-10-27
ATE107859T1 (de) 1994-07-15
FR2651435B1 (cg-RX-API-DMAC7.html) 1994-04-22
AU623805B2 (en) 1992-05-21
EP0417003B1 (fr) 1994-06-29
US5173483A (en) 1992-12-22
FR2651435A1 (fr) 1991-03-08
DE69010294D1 (de) 1994-08-04
CA2024728A1 (fr) 1991-03-08
JPH0399015A (ja) 1991-04-24

Similar Documents

Publication Publication Date Title
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
DK173883D0 (da) Substituerede 8-phenylxanthiner
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
SE8505488D0 (sv) Isosilybinfri silibinin
IS3814A (is) Aðferð til framleiðslu á lyfjablöndum
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
SE9801494D0 (sv) Novel use
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
IT8348294A0 (it) Composti e composizioni per il trattamento delle affezioni cardiocircolatorie e procedimento di preparazione
DK361282A (da) Fremgangsmaade til fremstilling af o-alkyl-o-carbamoylglycerophosphocholiner
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2061718T3 (es) Utilizacion de antigestagenos para la preparacion de medicamentos.
ES2071723T3 (es) Bencilseleniobenzoamidas de aminopiridinas y picolilaminas.
ES2018532B3 (es) Procedimiento para la preparacion de compuestos carbonilicos.
IT8047950A0 (it) Composizioni farmaceutiche impiegabili per il trattamento dell'ipertensione
DE3776488D1 (cg-RX-API-DMAC7.html)
ES2060162T3 (es) Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
DK161513C (da) Fremgangsmaade til fremstilling af n,n-dimethylaminomethylarylforbindelser
KR910009110U (ko) 방향용 양초의 구조